Search

01/07/2021 CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia
van der Ende, EL, Morenas-Rodriguez, E, McMillan, C, Grossman, M, Irwin, D, Sanchez-Valle, R, Graff, C, Vandenberghe, R, Pijnenburg, YAL, Laforce, R, Le Ber, I, Lleo, A, Haass, C, Suarez-Calvet, M, van Swieten, JC, Seelaar, H. CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia. NEUROBIOLOGY OF AGING. 2021; 103DOI:10.1016/j.neurobiolaging.2021.02.024. PMID:33896652. IF:5.133(Q2/4D).
01/07/2021 Defective involuntary attention to novelty in type 1 diabetes and impaired awareness of hypoglycaemia
Stantonyonge, N, Martinez-Horta, S, Sampedro, F, Sanchez-Saudinos, MB, Chico, A. Defective involuntary attention to novelty in type 1 diabetes and impaired awareness of hypoglycaemia. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 177DOI:10.1016/j.diabres.2021.108898. PMID:34098058. IF:8.180(Q1/2D).
01/07/2021 Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients
Delaby, C, Vialaret, J, Hirtz, C, Lefebvre, T, Herkert, M, Puy, H, Lasocki, S, Lehmann, S. Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients. Bioanalysis. 2021; 13(13)DOI:10.4155/bio-2021-0069. PMID:34100293. IF:2.695(Q3/6D).
01/07/2021 Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
Dierssen, M, Herault, Y, Helguera, P, de Lagran, MM, Vazquez, A, Christian, B, Carmona-Iragui, M, Wiseman, F, Mobley, W, Fisher, EMC, Brault, V, Esbensen, A, Jacola, LM, Potier, MC, Hamlett, ED, Abbeduto, L, Soriano, LD, Busciglio, J, Iulita, MF, Crispino, J, Malinge, S, Barone, E, Perluigi, M, Costanzo, F, Delabar, JM, Bartesaghi, R, Dekker, AD, De Deyn, P, Ormaechea, JF, Shaw, PA, Haydar, TF, Sherman, SL, Strydom, A, Bhattacharyya, A. Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society. Molecular Syndromology. 2021; 12(4)DOI:10.1159/000514437. PMID:34421499. IF:1.494(Q4/9D).
01/07/2021 Network interdigitations of Tau and amyloid-beta deposits define cognitive levels in aging
Kim, CM, Montal, V, Diez, I, Orwig, W, Sepulcre, J, Alzheimer's Dis Neuroimaging. Network interdigitations of Tau and amyloid-beta deposits define cognitive levels in aging. HUMAN BRAIN MAPPING. 2021; 42(10)DOI:10.1002/hbm.25350. PMID:33955621. IF:5.399(Q1/3D).
01/07/2021 EFFICACY OF CLINICAL HYPNOSIS IN FUNCTIONAL NEUROLOGICAL DISORDERS: EXPERIENCE IN A CONSECUTIVE SERIES OF 50 PATIENTS
Gironell, A, Badosa, JM, Roig, A, Tuccillo, R, Marconi, G, Munoz, M, Ribosa, R, Vallhonrat, AC, Linares, EJ, Puig, AR, Feixas, G. EFFICACY OF CLINICAL HYPNOSIS IN FUNCTIONAL NEUROLOGICAL DISORDERS: EXPERIENCE IN A CONSECUTIVE SERIES OF 50 PATIENTS. Revista De Psicoterapia. 2021; 32(119)DOI:10.33898/rdp.v32i119.472. PMID:. IF:(Q/D).
01/12/2022 Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Baumer, NT, Becker, ML, Capone, GT, Egan, K, Fortea, J, Handen, BL, Head, E, Hendrix, JE, Litovsky, RY, Strydom, A, Tapia, IE, Rafii, MS. Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group. Journal of Neurodevelopmental Disorders. 2022; 14(1)DOI:10.1186/s11689-022-09435-z. PMID:35321660. IF:4.900(Q1/3D).
27/06/2022 Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform
Ferrer, R, Zhu, N, Arranz, J, Porcel, I, El Bounasri, S, Sanchez, O, Torres, S, Julve, J, Lleo, A, Blanco-Vaca, F, Alcolea, D, Tondo, M. Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(7)DOI:10.1515/cclm-2022-0134. PMID:35405043. IF:6.800(Q1/2D).
13/05/2022 Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022)
Visser, PJ, Reus, LM, Gobom, J, Jansen, I, Dicks, E, van der Lee, SJ, Tsolaki, M, Verhey, FRJ, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Sleegers, K, Dobricic, V, Lovestone, S, Streffer, J, Vos, SJB, Bos, I, Smit, AB, Blennow, K, Scheltens, P, Teunissen, CE, Bertram, L, Zetterberg, H, Tijms, BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022). Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00540-0. PMID:35550177. IF:15.100(Q1/1D).
29/04/2022 Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
Illan-Gala, I, Nigro, S, VandeVrede, L, Falgas, N, Heuer, HW, Painous, C, Compta, Y, Marti, MJ, Montal, V, Pagonabarraga, J, Kulisevsky, J, Lleo, A, Fortea, J, Logroscino, G, Quattrone, A, Quattrone, A, Perry, DC, Gorno-Tempini, ML, Rosen, HJ, Grinberg, LT, Spina, S, La Joie, R, Rabinovici, GD, Miller, BL, Rojas, JC, Seeley, WW, Boxer, AL. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration. JAMA Network Open. 2022; 5(4)DOI:10.1001/jamanetworkopen.2022.9588. PMID:35486397. IF:13.800(Q1/1D).
26/04/2022 Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
Ruiz-Barrio, I, Horta-Barba, A, Illan-Gala, I, Kulisevsky, J, Pagonabarraga, J. Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.861585. PMID:35557621. IF:3.400(Q2/5D).
08/04/2022 Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
Gonzalez, AC, Irwin, DJ, Alcolea, D, McMillan, CT, Chen-Plotkin, A, Wolk, D, Sirisi, S, Dols-Icardo, O, Querol-Vilaseca, M, Illan-Gala, I, Santos-Santos, MA, Fortea, J, Lee, EB, Trojanowski, JQ, Grossman, M, Lleo, A, Belbin, O. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00534-y. PMID:35395770. IF:15.100(Q1/1D).
01/04/2022 New insights into the genetic etiology of Alzheimer's disease and related dementias
Bellenguez, C, Kucukali, F, Jansen, IE, Kleineidam, L, Moreno-Grau, S, Amin, N, Naj, AC, Campos-Martin, R, Grenier-Boley, B, Andrade, V, Holmans, PA, Boland, A, Damotte, V, van der Lee, SJ, Costa, MR, Kuulasmaa, T, Yang, Q, De Rojas, I, Bis, JC, Yaqub, A, Prokic, I, Chapuis, J, Ahmad, S, Giedraitis, V, Aarsland, D, Garcia-Gonzalez, P, Abdelnour, C, Alarcon-Martin, E, Alcolea, D, Alegret, M, Alvarez, I, Alvarez, V, Armstrong, NJ, Tsolaki, A, Antunez, C, Appollonio, I, Arcaro, M, Archetti, S, Pastor, AA, Arosio, B, Athanasiu, L, Bailly, H, Banaj, N, Baquero, M, Barral, S, Beiser, A, Pastor, AB, Below, JE, Benchek, P, Benussi, L, Berr, C, Besse, C, Bessi, V, Binetti, G, Bizarro, A, Blesa, R, Boada, M, Boerwinkle, E, Borroni, B, Boschi, S, Bossu, P, Brathen, G, Bressler, J, Bresner, C, Brodaty, H, Brookes, KJ, Brusco, LI, Buiza-Rueda, D, Burger, K, Burholt, V, Bush, WS, Calero, M, Cantwell, LB, Chene, G, Chung, J, Cuccaro, ML, Cecchetti, R, Cervera-Carles, L, Charbonnier, C, Chen, HH, Chillotti, C, Ciccone, S, Claassen, JAHR, Clark, C, Conti, E, Corma-Gomez, A, Costantini, E, Custodero, C, Daian, D, Dalmasso, MC, Daniele, A, Dardiotis, E, Dartigues, JF, de Deyn, PP, Lopes, KD, De Witte, LD, Debette, S, Deckert, J, del Ser, T, Denning, N, Destefano, A, Dichgans, M, Diehl-Schmid, J, Diez-Fairen, M, Rossi, PD, Djurovic, S, Duron, E, Duzel, E, Dufouil, C, Eiriksdottir, G, Engelborghs, S, Escott-Price, V, Espinosa, A, Ewers, M, Faber, KM, Fabrizio, T, Nielsen, SF, Fardo, DW, Farotti, L, Fenoglio, C, Fernandez-Fuertes, M, Ferrari, R, Ferreira, CB, Ferri, E, Fin, B, Fischer, P, Fladby, T, Fliessbach, K, Fongang, B, Fornage, M, Fortea, J, Foroud, TM, Fostinelli, S, Fox, NC, Franco-Macias, E, Bullido, MJ, Frank-Garcia, A, Froelich, L, Fulton-Howard, B, Galimberti, D, Garcia-Alberca, JM, Garcia-Madrona, S, Garcia-Ribas, G, Ghidoni, R, Giegling, I, Giorgio, G, Goate, AM, Goldhardt, O, Gomez-Fonseca, D, Gonzalez-Perez, A, Graff, C, Grande, G, Green, E, Grimmer, T, Grunblatt, E, Grunin, M, Gudnason, V, Guetta-Baranes, T, Haapasalo, A, Hadjigeorgiou, G, Haines, JL, Hamilton-Nelson, KL, Hampel, H, Hanon, O, Hardy, J, Hartmann, AM, Hausner, L, Harwood, J, Heilmann-Heimbach, S, Helisalmi, S, Heneka, MT, Hernandez, I, Herrmann, MJ, Hoffmann, P, Holmes, C, Holstege, H, Vilas, RH, Hulsman, M, Humphrey, J, Biessels, GJ, Jian, XQ, Johansson, C, Jun, GR, Kastumata, Y, Kauwe, J, Kehoe, PG, Kilander, L, Stahlbom, AK, Kivipelto, M, Koivisto, A, Kornhuber, J, Kosmidis, MH, Kukull, WA, Kuksa, PP, Kunkle, BW, Kuzma, AB, Lage, C, Laukka, EJ, Launer, L, Lauria, A, Lee, CY, Lehtisalo, J, Lerch, O, Lleo, A, Longstreth, W, Lopez, O, de Munain, AL, Love, S, Lowemark, M, Luckcuck, L, Lunetta, KL, Ma, YY, Macias, J, Macleod, CA, Maier, W, Mangialasche, F, Spallazzi, M, Marquie, M, Marshall, R, Martin, ER, Montes, AM, Rodriguez, CM, Masullo, C, Mayeux, R, Mead, S, Mecocci, P, Medina, M, Meggy, A, Mehrabian, S, Mendoza, S, Menendez-Gonzalez, M, Mir, P, Moebus, S, Mol, M, Molina-Porcel, L, Montrreal, L, Morelli, L, Moreno, F, Morgan, K, Mosley, T, Nothen, MM, Muchnik, C, Mukherjee, S, Nacmias, B, Ngandu, T, Nicolas, G, Nordestgaard, BG, Olaso, R, Orellana, A, Orsini, M, Ortega, G, Padovani, A, Paolo, C, Papenberg, G, Parnetti, L, Pasquier, F, Pastor, P, Peloso, G, Perez-Cordon, A, Perez-Tur, J, Pericard, P, Peters, O, Pijnenburg, YAL, Pineda, JA, Pinol-Ripoll, G, Pisanu, L, Polak, T, Popp, J, Posthuma, D, Priller, J, Puerta, R, Quenez, O, Quintela, I, Thomassen, JQ, Rabano, A, Rainero, I, Rajabli, F, Ramakers, I, Real, LM, Reinders, MJT, Reitz, C, Reyes-Dumeyer, D, Ridge, P, Riedel-Heller, S, Riederer, P, Roberto, N, Rodriguez-Rodriguez, E, Rongve, A, Allende, IR, Rosende-Roca, M, Royo, JL, Rubino, E, Rujescu, D, Saez, ME, Sakka, P, Saltvedt, I, Sanchez-Arjona, MB, Sanchez-Garcia, F, Juan, PS, Sanchez-Valle, R, Sando, SB, Sarnowski, C, Satizabal, CL, Scamosci, M, Scarmeas, N, Scarpini, E, Scheltens, P, Scherbaum, N, Scherer, M, Schmid, M, Schneider, A, Schott, JM, Selbaek, G, Seripa, D, Serrano, M, Sha, J, Shadrin, AA, Skrobot, O, Slifer, S, Snijders, GJL, Soininen, H, Solfrizzi, V, Solomon, A, Song, Y, Sorbi, S, Sotolongo-Grau, O, Spalletta, G, Spottke, A, Squassina, A, Stordal, E, Tartan, JP, Tarraga, L, Tesi, N, Thalamuthu, A, Thomas, T, Tosto, G, Traykov, L, Tremolizzo, L, Tybjaeg-Hansen, A, Uitterlinden, A, Ullgren, A, Ulstein, I, Valero, S, Valladares, O, Van Broeckhoven, C, Vance, J, Vardarajan, BN, van der Lugt, A, Van Dongen, J, van Rooij, J, van Swieten, J, Vandenberghe, R, Verhey, F, Vidal, JS, Vogelgsang, J, Vyhnalek, M, Wagner, M, Wallon, D, Wang, LS, Wang, RQ, Weinhold, L, Wiltfang, J, Windle, G, Woods, B, Yannakoulia, M, Zare, H, Zhao, Y, Zhang, XL, Zhu, CC, Zulaica, M, Farrer, LA, Psaty, BM, Ghanbari, M, Raj, T, Sachdev, P, Mather, K, Jessen, F, Ikram, MA, de Mendonca, A, Hort, J, Tsolaki, M, Pericak-Vance, MA, Amouyel, P, Williams, J, Frikke-Schmidt, R, Clarimon, J, Deleuze, JF, Rossi, G, Seshadri, S, Andreassen, OA, Ingelsson, M, Hiltunen, M, Sleegers, K, Schellenberg, GD, van Duijn, CM, Sims, R, van der Flier, WM, Ruiz, A, Ramirez, A, Lambert, JC. New insights into the genetic etiology of Alzheimer's disease and related dementias. NATURE GENETICS. 2022; 54(4)DOI:10.1038/s41588-022-01024-z. PMID:36260740. IF:30.800(Q1/1D).
01/04/2022 Public perceptions of brain health: an international, online cross-sectional survey
Budin-Ljosne, I, Mowinckel, AM, Friedman, BB, Ebmeier, KP, Drevon, CA, Carver, RB, Zsoldos, E, Fredheim, NAG, Sorensen, O, Baare, WFC, Madsen, KS, Fjell, AM, Kievit, RA, Ghisletta, P, Bartres-Faz, D, Nawijn, L, Sole-Padulles, C, Walhovd, KB, Duzel, S, Zasyekina, L, Iulita, MF, Ferretti, MT. Public perceptions of brain health: an international, online cross-sectional survey. BMJ Open. 2022; 12(4)DOI:10.1136/bmjopen-2021-057999. PMID:35437254. IF:2.900(Q2/5D).
01/04/2022 Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications
Altuna, M, Olmedo-Saura, G, Carmona-Iragui, M, Fortea, J. Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(8)DOI:10.3390/ijms23084307. PMID:35457126. IF:5.600(Q1/3D).
30/03/2022 Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's Disease
Gimenez, S, Farré A, Morente, F, Videla, L, Gutierrez, M, Clos, S, Fernandez, A, Blanco, M, Altuna, M, Pegueroles, J, Asensio, A, Benejam, B, Batista, M, Barroeta, I, Fortuna, A, Fortea, J, Mayos, M. Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's Disease. Frontiers in Neuroscience. 2022; 16DOI:10.3389/fnins.2022.838412. PMID:35431793. IF:4.300(Q2/4D).
28/03/2022 Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Visser, PJ, Reus, LM, Gobom, J, Jansen, I, Dicks, E, Van der Lee, SJ, Tsolaki, M, Verhey, FRJ, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Sleegers, K, Dobricic, V, Lovestone, S, Streffer, J, Vos, SJB, Bos, I, Smit, AB, Blennow, K, Scheltens, P, Teunissen, CE, Bertram, L, Zetterberg, H, Tijms, BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00521-3. PMID:35346299. IF:15.100(Q1/1D).
21/03/2022 Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset
Homann, J, Osburg, T, Ohlei, O, Dobricic, V, Deecke, L, Bos, I, Vandenberghe, R, Gabel, S, Scheltens, P, Teunissen, CE, Engelborghs, S, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Lleo, A, Alcolea, D, Popp, J, Clark, C, Peyratout, G, Martinez-Lage, P, Tainta, M, Dobson, RJB, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Wittig, M, Franke, A, Lill, CM, Blennow, K, Zetterberg, H, Lovestone, S, Streffer, J, ten Kate, M, Vos, SJB, Barkhof, F, Visser, PJ, Bertram, L. Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.840651. PMID:35386118. IF:4.800(Q2/3D).
01/03/2022 Neuropsychological deficits in patients with cognitive complaints after COVID-19
Garcia-Sanchez, C, Calabria, M, Grunden, N, Pons, C, Arroyo, JA, Gomez-Anson, B, Lleo, A, Alcolea, D, Belvis, R, Morollon, N, Mur, I, Pomar, V, Domingo, P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3)DOI:10.1002/brb3.2508. PMID:35137561. IF:3.100(Q2/3D).
09/02/2022 Cortical microstructure in primary progressive aphasia: a multicenter study
Illan-Gala, I, Montal, V, Borrego-Ecija, S, Mandelli, ML, Falgas, N, Welch, AE, Pegueroles, J, Santos-Santos, M, Bejanin, A, Alcolea, D, Dols-Icardo, O, Belbin, O, Sanchez-Saudinos, MB, Bargallo, N, Gonzalez-Ortiz, S, Llado, A, Blesa, R, Dickerson, BC, Rosen, HJ, Miller, BL, Lleo, A, Gorno-Tempini, ML, Sanchez-Valle, R, Fortea, J. Cortical microstructure in primary progressive aphasia: a multicenter study. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00974-0. PMID:35139897. IF:9.000(Q1/1D).
01/02/2022 Fluid markers of synapse degeneration in synucleinopathies
Gonzalez, AC, Belbin, O. Fluid markers of synapse degeneration in synucleinopathies. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02467-8. PMID:35147800. IF:3.300(Q2/5D).
01/02/2022 Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Delaby, C, Alcolea, D, Hirtz, C, Vialaret, J, Kindermans, J, Morichon, L, Fortea, J, Belbin, O, Gabelle, A, Blennow, K, Zetterberg, H, Lleo, A, Lehmann, S. Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02474-9. PMID:35169889. IF:3.300(Q2/5D).
01/02/2022 The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone
Delaby, C, Estelles, T, Zhu, NU, Arranz, J, Barroeta, I, Carmona-Iragui, M, Illan-Gala, I, Santos-Santos, MA, Altuna, M, Sala, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Subirana, A, Tondo, M, Blanco-Vaca, F, Lehmann, S, Belbin, O, Blesa, R, Fortea, J, Lleo, A, Alcolea, D. The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00967-z. PMID:35105351. IF:9.000(Q1/1D).
01/02/2022 Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022)
Delaby, C, Lehmann, S. Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022). JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02473-w. PMID:35175386. IF:3.300(Q2/5D).
18/01/2022 Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Reyes-Leiva, D, Dols-Icardo, O, Sirisi, S, Cortes-Vicente, E, Turon-Sans, J, De Luna, N, Blesa, R, Belbin, O, Montal, V, Alcolea, D, Fortea, J, Lleo, A, Rojas-Garcia, R, Illan-Gala, I. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology. 2022; 12DOI:10.3389/fneur.2021.750543. PMID:35115992. IF:3.400(Q2/5D).
01/01/2022 Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
Padilla, C, Montal, V, Walpert, MJ, Hong, YT, Fryer, TD, Coles, JP, Aigbirhio, FI, Hartley, SL, Cohen, AD, Tudorascu, DL, Christian, BT, Handen, BL, Klunk, WE, Holland, AJ, Zaman, SH. Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022; 14(1)DOI:10.1002/dad2.12288. PMID:35386472. IF:(Q/D).
02/11/2022 Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients
Lennol, MP, Sanchez-Dominguez, I, Cuchillo-Ibanez, I, Camporesi, E, Brinkmalm, G, Alcolea, D, Fortea, J, Lleo, A, Soria, G, Aguado, F, Zetterberg, H, Blennow, K, Saez-Valero, J. Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01108-2. PMID:36324176. IF:9.000(Q1/1D).
01/11/2022 Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Jansen, RE, van der Lee, SJ, Gomez-Fonseca, D, de Rojas, I, Dalmasso, MC, Grenier-Boley, B, Zettergren, A, Mishra, A, Ali, M, Andrade, V, Bellenguez, C, Kleineidam, L, Kucukali, F, Sung, YJ, Tesi, N, Vromen, EM, Wightman, DP, Alcolea, D, Alegret, M, Alvarez, I, Amouyel, P, Athanasiu, L, Bahrami, S, Bailly, H, Belbin, O, Bergh, S, Bertram, L, Biessels, GJ, Blennow, K, Blesa, R, Boada, M, Boland, A, Buerger, K, Carracedo, A, Cervera-Carles, L, Chene, G, Claassen, JAHR, Debette, S, Deleuze, JF, de Deyn, PP, Diehl-Schmid, J, Djurovic, S, Dols-Icardo, O, Dufouil, C, Duron, E, Duzel, E, Fladby, T, Fortea, J, Frolich, L, Garcia-Gonzalez, P, Garcia-Martinez, M, Giegling, I, Goldhardt, O, Gobom, J, Grimmer, T, Haapasalo, A, Hampel, H, Hanon, O, Hausner, L, Heilmann-Heimbach, S, Helisalmi, S, Heneka, MT, Hernandez, I, Herukka, SK, Holstege, H, Jarholm, J, Kern, S, Knapskog, AB, Koivisto, AM, Kornhuber, J, Kuulasmaa, T, Lage, C, Laske, C, Leinonen, V, Lewczuk, P, Lleo, A, de Munain, AL, Lopez-Garcia, S, Maier, W, Marquie, M, Mol, MO, Montrreal, L, Moreno, F, Moreno-Grau, S, Nicolas, G, Nothen, MM, Orellana, A, Palhaugen, L, Papma, JM, Pasquier, F, Perneczky, R, Peters, O, Pijnenburg, YAL, Popp, J, Posthuma, D, Pozueta, A, Priller, J, Puerta, R, Quintela, I, Ramakers, I, Rodriguez-Rodriguez, E, Rujescu, D, Saltvedt, I, Sanchez-Juan, P, Scheltens, P, Scherbaum, N, Schmid, M, Schneider, A, Selbaek, G, Selnes, P, Shadrin, A, Skoog, I, Soininen, H, Tarraga, L, Teipel, S, Tijms, B, Tsolaki, M, Van Broeckhoven, C, Van Dongen, J, van Swieten, JC, Vandenberghe, R, Vidal, JS, Visser, PJ, Vogelgsang, J, Waern, M, Wagner, M, Wiltfang, J, Wittens, MMJ, Zetterberg, H, Zulaica, M, van Duijn, CM, Bjerke, M, Engelborghs, S, Jessen, F, Teunissen, CE, Pastor, P, Hiltunen, M, Ingelsson, M, Andreassen, OA, Clarimon, J, Sleegers, K, Ruiz, A, Ramirez, A, Cruchaga, C, Lambert, JC, van der Flier, W. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers. ACTA NEUROPATHOLOGICA. 2022; 144(5)DOI:10.1007/s00401-022-02454-z. PMID:36066633. IF:12.700(Q1/1D).
01/10/2022 The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary
Hampel, H, Elhage, A, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary. Neurodegenerative Disease Management. 2022; 12(5)DOI:10.2217/nmt-2022-0012. PMID:35866715. IF:(Q/D).
01/10/2022 Myelin loss in C9orf72 hexanucleotide expansion carriers
Sirisi, S, Querol-Vilaseca, M, Dols-Icardo, O, Pegueroles, J, Montal, V, Munoz, L, Torres, S, Ferrer-Raventos, P, Iulita, MF, Sanchez-Aced, E, Blesa, R, Illan-Gala, I, Molina-Porcel, L, Borrego-Ecija, S, Sanchez-Valle, R, Clarimon, J, Belbin, O, Fortea, J, Lleo, A. Myelin loss in C9orf72 hexanucleotide expansion carriers. JOURNAL OF NEUROSCIENCE RESEARCH. 2022; 100(10)DOI:10.1002/jnr.25100. PMID:35766328. IF:4.200(Q2/4D).
06/09/2022 Early Motor Changes in Genetic Frontotemporal Dementia
Lleo, A, Illan-Gala, I. Early Motor Changes in Genetic Frontotemporal Dementia. NEUROLOGY. 2022; 99(10)DOI:10.1212/WNL.0000000000200967. PMID:36219793. IF:9.900(Q1/1D).
03/09/2022 Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease
Benejam, B, Aranha, MR, Videla, L, Padilla, C, Valldeneu, S, Fernandez, S, Altuna, M, Carmona-Iragui, M, Barroeta, I, Iulita, MF, Montal, V, Pegueroles, J, Bejanin, A, Gimenez, S, Gonzalez-Ortiz, S, Videla, S, Bartres-Faz, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01064-x. PMID:36057615. IF:9.000(Q1/1D).
01/09/2022 Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleo, A, Maurino, J. Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain. Neurology and Therapy. 2022; 11(3)DOI:10.1007/s40120-022-00367-3. PMID:35648383. IF:3.700(Q2/4D).
01/09/2022 Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies
Perez-Oliveira, S, Alvarez, I, Rosas, I, Menendez-Gonzalez, M, Blazquez-Estrada, M, Aguilar, M, Corte, D, Buongiorno, M, Molina-Porcel, L, Aldecoa, I, Marti, MJ, Sanchez-Juan, P, Infante, J, Gonzalez-Aramburu, I, Garcia-Gonzalez, P, Rosende-Roca, M, Boada, M, Ruiz, A, Perinan, MT, Macias-Garcia, D, Munoz-Delgado, L, Gomez-Garre, P, Mir, P, Clarimon, J, Lleo, A, Alcolea, D, De la Casa-Fages, B, Duarte, I, Alvarez, V, Pastor, P. Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies. MOVEMENT DISORDERS. 2022; 37(9)DOI:10.1002/mds.29153. PMID:35852957. IF:8.600(Q1/1D).
05/08/2022 Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
Videla, L, Benejam, B, Pegueroles, J, Carmona-Iragui, M, Padilla, C, Fernandez, S, Barroeta, I, Altuna, M, Valldeneu, S, Garzon, D, Ribas, L, Montal, V, Martinez, JA, Aranha, MR, Alcolea, D, Bejanin, A, Iulita, MF, Ces, SV, Blesa, R, Lleo, A, Fortea, J. Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome. JAMA Network Open. 2022; 5(8)DOI:10.1001/jamanetworkopen.2022.25573. PMID:35930282. IF:13.800(Q1/1D).
01/08/2022 HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis
Borras, C, Mercer, A, Sirisi, S, Alcolea, D, Escola-Gil, JC, Blanco-Vaca, F, Tondo, M. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(16)DOI:10.3390/ijms23169356. PMID:36012637. IF:5.600(Q1/3D).
27/07/2022 Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes
Montal, V, Diez, I, Kim, CM, Orwig, W, Bueicheku, E, Gutierrez-Zuniga, R, Bejanin, A, Pegueroles, J, Dols-Icardo, O, Vannini, P, El-Fakhri, G, Johnson, KA, Sperling, RA, Fortea, J, Sepulcre, J. Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Science Translational Medicine. 2022; 14(655)DOI:10.1126/scitranslmed.abn7273. PMID:35895837. IF:17.100(Q1/1D).
01/07/2022 Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
Orellana, A, Garcia-Gonzalez, P, Valero, S, Montrreal, L, de Rojas, I, Hernandez, I, Rosende-Roca, M, Vargas, L, Tartari, JP, Antonio, EED, Bojaryn, U, Narvaiza, L, Alarcon-Martin, E, Alegret, M, Alcolea, D, Lleo, A, Tarraga, L, Pytel, V, Cano, A, Marquie, M, Boada, M, Ruiz, A. Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23136891. PMID:35805894. IF:5.600(Q1/3D).
14/06/2022 Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease
Aranha, MR, Fortea, J, Carmona-Iragui, M. Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease. NEUROLOGY. 2022; 98(24)DOI:10.1212/WNL.0000000000200704. PMID:35470138. IF:9.900(Q1/1D).
03/06/2022 Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K, Shah, Z, Chia, R, Scholz, SW, Alcolea, D., Clarimón, J., Fortea, J., Lleó, A., Int LBD Genomics Consortium. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. BRAIN. 2022; 145(5)DOI:10.1093/brain/awab402. PMID:35381062. IF:14.500(Q1/1D).
01/06/2022 Connectomic-genetic signatures in the cerebral small vessel disease
Gutiérrez-Zúñiga R., Diez I., Bueichekú E., Kim C.-M., Orwig W., Montal V., Fuentes B., Díez-Tejedor E., Fernández M.G., Sepulcre J.. Connectomic-genetic signatures in the cerebral small vessel disease. NEUROBIOLOGY OF DISEASE. 2022; 167DOI:10.1016/j.nbd.2022.105671. PMID:35231560. IF:6.100(Q1/2D).
01/06/2022 DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients
Moreau, M, Carmona-Iragui, M, Altuna, M, Dalzon, L, Barroeta, I, Vilaire, M, Durand, S, Fortea, J, Rebillat, AS, Janel, N. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. Biomedicines. 2022; 10(6)DOI:10.3390/biomedicines10061380. PMID:35740400. IF:4.700(Q1/3D).
01/02/2022 Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders
Ramírez S., Haddad-Tóvolli R., Radosevic M., Toledo M., Pané A., Alcolea D., Ribas V., Milà-Guasch M., Pozo M., Obri A., Eyre E., Gómez-Valadés A.G., Chivite I., Van Eeckhout T., Zalachoras I., Altirriba J., Bauder C., Imbernón M., Garrabou G., Garcia-Ruiz C., Nogueiras R., Soto D., Gasull X., Sandi C., Brüning J.C., Fortea J., Jiménez A., Fernández-Checa J.C., Claret M.. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metabolism. 2022; 34(2)DOI:10.1016/j.cmet.2021.12.023. PMID:35108514. IF:29.000(Q1/1D).
01/01/2022 Neurofilaments contribution in clinic: state of the art
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments contribution in clinic: state of the art. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1034684. PMID:36389064. IF:4.800(Q2/3D).
01/02/2025 Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
Guillén, N, Contador, J, Buongiorno, M, Alvarez, I, Culell, N, Alcolea, D, Lleó, A, Fortea, J, Piñol-Ripoll, G, Carnes-Vendrell, A, Ispierto, ML, Vilas, D, Puig-Pijoan, A, Fernández-Lebrero, A, Balasa, M, Sánchez-Valle, R, Lladó, A. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(1)DOI:10.1007/s00406-023-01701-y. PMID:37898567. IF:3.700(Q1/3D).
01/02/2025 Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis
Dols-Icardo, O, Carbayo, A, Jericó, I, Blasco-Martínez, O, Alvarez-Sánchez, E, Pérez, MAL, Bernal, S, Rodríguez-Santiago, B, Cusco, I, Turon-Sans, J, Cabezas-Torres, M, Caballero-Avila, M, Vesperinas, A, Llansó, L, Pagola-Lorz, I, Torné, L, Valle-Tamayo, N, Muñoz, L, Rubio-Guerra, S, Illán-Gala, I, Cortés-Vicente, E, Gelpi, E, Rojas-García, R. Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(2)DOI:10.1136/jnnp-2024-333834. PMID:38960585. IF:7.500(Q1/1D).
23/09/2024 Alzheimer Dementia Among Individuals With Down Syndrome
Rubenstein, E, Tewolde, S, Michals, A, Weuve, J, Fortea, J, Fox, MP, Jimenez, MP, Scott, A, Tripodis, Y, Skotko, BG. Alzheimer Dementia Among Individuals With Down Syndrome. JAMA Network Open. 2024; 7(9)DOI:10.1001/jamanetworkopen.2024.35018. PMID:39312235. IF:9.700(Q1/1D).
25/06/2024 Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019
Rubenstein, E, Tewolde, S, Skotko, BG, Michals, A, Fortea, J. Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. 2024; 196(4)DOI:10.1002/ajmg.c.32097. PMID:38925597. IF:4.400(Q1/2D).
25/06/2024 What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
Lleó, A, Alcolea, D. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. NEUROLOGY. 2024; 102(12)DOI:10.1212/WNL.0000000000209505. PMID:38830183. IF:8.500(Q1/1D).
13/06/2024 Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Navarro-Pérez, MP, González-Quintanilla, V, Muñoz-Vendrell, A, Madrigal, E, Alpuente, A, Latorre, G, Molina, F, Monzón, MJ, Medrano, V, García-Azorín, D, González-Oria, C, Gago-Veiga, A, Velasco, F, Beltrán, I, Morollón, N, Viguera, J, Casas-Limón, J, Rodriguez-Vico, J, Cuadrado, E, Irimia, P, Iglesias, F, Guerrero-Peral, áL, Belvís, R, Pozo-Rosich, P, Pascual, J, Santos-Lasaosa, S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1417831. PMID:38938776. IF:2.800(Q2/5D).
05/06/2024 Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum
Carbayo, A, Borrego-Écija, S, Turon-Sans, J, Cortés-Vicente, E, Molina-Porcel, L, Gascón-Bayarri, J, Rubio, MA, Povedano, M, Gámez, J, Sotoca, J, Juntas-Morales, R, Almendrote, M, Marquié, M, Sánchez-Valle, R, Illán-Gala, I, Dols-Icardo, O, Rubio-Guerra, S, Bernal, S, Caballero-Avila, M, Vesperinas, A, Gelpi, E, Rojas-García, R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7)DOI:10.1093/brain/awae011. PMID:38227807. IF:11.700(Q1/1D).
17/05/2024 The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people
Jacobs, T, Jacobson, SR, Fortea, J, Berger, JS, Vedvyas, A, Marsh, K, He, TS, Gutierrez-Jimenez, E, Fillmore, NR, Gonzalez, M, Figueredo, L, Gaggi, NL, Plaska, CR, Pomara, N, Blessing, E, Betensky, R, Rusinek, H, Zetterberg, H, Blennow, K, Glodzik, L, Wisniweski, TM, de Leon, MJ, Osorio, RS, Ramos-Cejudo, J. The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people. Immunity & Ageing. 2024; 21(1)DOI:10.1186/s12979-024-00435-2. PMID:38760856. IF:5.600(Q1/1D).
11/05/2024 Addressing challenges in health care and research for people with Down syndrome
Fortea, J, McGlinchey, E, Espinosa, JM, Rafii, MS. Addressing challenges in health care and research for people with Down syndrome. LANCET. 2024; 403(10439)DOI:10.1016/S0140-6736(24)00478-1. PMID:38521088. IF:88.500(Q1/1D).
23/04/2024 On the road to biological blood diagnosis of Alzheimer's disease?
Delaby, C, Lehmann, S. On the road to biological blood diagnosis of Alzheimer's disease?. M S-MEDECINE SCIENCES. 2024; 40(4)DOI:10.1051/medsci/2024037. PMID:38651960. IF:0.400(Q4/10D).
01/04/2024 CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
García-Azorín, D, Martínez-Badillo, C, Muñiz, JC, Gago-Veiga, AB, Sánchez, NM, González-Quintanilla, V, Porta-Etessam, J, Sierra-Mencia, A, Gonzalez-Garcia, N, González-Osorio, Y, Polanco-Fernandez, M, Recio-García, A, Nieto, RB, Guerrero-Peral, AL. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. CEPHALALGIA. 2024; 44(4)DOI:10.1177/03331024241248833. PMID:38663908. IF:4.600(Q1/2D).
28/03/2024 A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors
Swift, IJ, Rademakers, R, Finch, N, Baker, M, Ghidoni, R, Benussi, L, Binetti, G, Rossi, G, Synofzik, M, Wilke, C, Mengel, D, Graff, C, Takada, LT, Sanchez-Valle, R, Antonell, A, Galimberti, D, Fenoglio, C, Serpente, M, Arcaro, M, Schreiber, S, Vielhaber, S, Arndt, P, Santana, I, Almeida, MR, Moreno, F, Barandiaran, M, Gabilondo, A, Stubert, J, Gomez-Tortosa, E, Agueero, P, Sainz, MJ, Gohda, T, Murakoshi, M, Kamei, N, Kittel-Schneider, S, Reif, A, Weigl, J, Jian, JL, Liu, CJ, Serrero, G, Greither, T, Theil, G, Lohmann, E, Gazzina, S, Bagnoli, S, Coppola, G, Bruni, A, Quante, M, Kiess, W, Hiemisch, A, Jurkutat, A, Block, MS, Carlson, AM, Bråthen, G, Sando, SB, Grontvedt, GR, Lauridsen, C, Heslegrave, A, Heller, C, Abel, E, Gómez-Núñez, A, Puey, R, Arighi, A, Rotondo, E, Jiskoot, LC, Meeter, LHH, Duraes, J, Lima, M, Tábuas-Pereira, M, Lemos, J, Boeve, B, Petersen, RC, Dickson, DW, Graff-Radford, NR, Leber, I, Sellami, L, Lamari, F, Clot, F, Borroni, B, Cantoni, V, Rivolta, J, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I, Andres-Cerezo, L, Van Damme, P, Clarimon, J, Steinacker, P, Feneberg, E, Otto, M, van der Ende, EL, van Swieten, JC, Seelaar, H, Zetterberg, H, Sogorb-Esteve, A, Rohrer, JD. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Research & Therapy. 2024; 16(1)DOI:10.1186/s13195-024-01420-z. PMID:38539243. IF:7.600(Q1/1D).
08/03/2024 Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder
Pardo, J, Montal, V, Campabadal, A, Oltra, J, Uribe, C, Roura, I, Bargalló, N, Martí, MJ, Compta, Y, Iranzo, A, Fortea, J, Junqué, C, Segura, B. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder. MOVEMENT DISORDERS. 2024; 39(5)DOI:10.1002/mds.29761. PMID:38456361. IF:7.600(Q1/1D).
01/03/2024 Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Ashton N.J., Brum W.S., Di Molfetta G., Benedet A.L., Arslan B., Jonaitis E., Langhough R.E., Cody K., Wilson R., Carlsson C.M., Vanmechelen E., Montoliu-Gaya L., Lantero-Rodriguez J., Rahmouni N., Tissot C., Stevenson J., Servaes S., Therriault J., Pascoal T., Lleó A., Alcolea D., Fortea J., Rosa-Neto P., Johnson S., Jeromin A., Blennow K., Zetterberg H.. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurology. 2024; 81(3)DOI:10.1001/jamaneurol.2023.5319. PMID:38252443. IF:21.300(Q1/1D).
01/02/2024 Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum
Lorca-Puls DL, Gajardo-Vidal A, Mandelli ML, Illán-Gala I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno-Tempini ML. Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. BRAIN. 2024; 147(2)DOI:10.1093/brain/awad327. PMID:37769652. IF:11.700(Q1/1D).
01/02/2024 Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
Bejanin, A, Villain, N. Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease. LANCET NEUROLOGY. 2024; 23(2)DOI:10.1016/S1474-4422(23)00501-X. PMID:38267172. IF:45.500(Q1/1D).